Canopy Growth

Canopy Growth

Pharmaceuticals
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.

$320.3M

Market Cap • 10/16/2026

2009

(17 years)

Founded

2014

(12 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Canada

Canada

Country

Valuation

P/B

0,7

P/S

1,5

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,1

EPS

—

Market Cap

Market Cap

320,3M

EV

248,9M

EV/Revenue

1,2

EV/EBITDA

-2,8

EV/EBIT

-2,2

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-75,2%

Total Yield

-75,2%

Payout

0%

Retained Earnings

-7,8B

Profitability

Gross Margin

25,1%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

1,6%

Capex/D&A

13%

Capex/OCF

-6,1%

SBC/OCF

—

% PPE

28,2%

% Goodwill

5%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-14,4%

CAGR Op. Income 5Y

-35%

CAGR Net Income 5Y

-28,6%

CAGR EPS 5Y

-56,1%

CAGR OCF 5Y

-33,1%

Leverage

N.D./EBITDA

0,8

Debt/Equity

0%

Current Ratio

3

Quick Ratio

2,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium